spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayly, A. C.
Right arrow Articles by Roberts, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayly, A. C.
Right arrow Articles by Roberts, R. A.

Journal of Cell Science, Vol 104, Issue 2 307-315, Copyright © 1993 by Company of Biologists

JOURNAL ARTICLES

Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis

AC Bayly, NJ French, C Dive and RA Roberts
Molecular Pharmacology and Toxicology Laboratory, School of Biological Sciences, University of Manchester, England.

A range of hepatoma cell lines (RH1, HTC, FaO, 7800C1 and MH1C1), has been studied with the aim of establishing an in vitro model to investigate the molecular mechanisms of hepatocarcinogenicity induced by the peroxisome proliferator class of non-genotoxic carcinogens. In view of speculation that peroxisome proliferators suppress hepatocyte apoptosis in vivo, we have placed particular emphasis on evaluating whether hepatoma cell lines retain the ability to undergo apoptotic cell death. Expression of the liver-specific differentiation marker albumin and the peroxisome proliferator-activated receptor (PPAR) was highest in the Reuber hepatoma cell line, FaO. This cell line also demonstrated the most marked response to the peroxisome proliferator nafenopin with a 2.2-fold induction of the microsomal enzyme cytochrome p450IVA1. This response was found to display intercellular heterogeneity by immunocytochemistry. Thus, the FaO cell line maintained characteristics of hepatocytes, both in vivo and in vitro, in terms of expression of constitutive and inducible markers. However, none of the cell lines tested mirrored the hyperplastic response of hepatocytes to nafenopin, since no increase in cell growth kinetics was observed on addition of nafenopin to the growth medium. The mode of cell death in confluent FaO cultures was characterised as apoptosis, by fluorescence microscopy and agarose gel electrophoresis of extracted DNA. Cells detaching from confluent FaO cultures exhibited chromatin condensation and DNA fragmentation patterns characteristic of cels undergoing apoptotic death.Interestingly, no apoptosis was seen in monolayer cells, suggesting that apoptosis in vitro is associated with cell shrinkage and detachment similar to that documented for the liver in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Toxicol SciHome page
H. P. Glauert, A. Eyigor, J. C. Tharappel, S. Cooper, E. Y. Lee, and B. T. Spear
Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-{kappa}B in Mice Administered the Peroxisome Proliferator Wy-14,643
Toxicol. Sci., April 1, 2006; 90(2): 331 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. M. Shipley, C. H. Hurst, S. S. Tanaka, F. L. DeRoos, J. L. Butenhoff, A. M. Seacat, and D. J. Waxman
trans-Activation of PPAR{alpha} and Induction of PPAR{alpha} Target Genes by Perfluorooctane-Based Chemicals
Toxicol. Sci., July 1, 2004; 80(1): 151 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear
Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate
Toxicol. Sci., October 1, 2003; 75(2): 300 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
V Goll, C Viollon-Abadie, L Nicod, and L Richert
Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines
Human and Experimental Toxicology, March 1, 2000; 19(3): 193 - 202.
[Abstract] [PDF]

Home page
 J. Lipid Res.Home page
S. Y. Moya-Camarena, J. P. V. Heuvel, S. G. Blanchard, L. A. Leesnitzer, and M. A. Belury
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR{alpha}
J. Lipid Res., August 1, 1999; 40(8): 1426 - 1433.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
S. Chevalier and R.A. Roberts
G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin
Carcinogenesis, July 1, 1999; 20(7): 1209 - 1213.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K.-I. Ohtani, H. Shimizu, N. Sato, and M. Mori
Troglitazone (CS-045) Inhibits {beta}-Cell Proliferation Rate Following Stimulation of Insulin Secretion in HIT-T 15 Cells
Endocrinology, January 1, 1998; 139(1): 172 - 178.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam
Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells
J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium
J. Cell Sci., March 1, 1996; 109(3): 631 - 642.
[Abstract] [PDF]


© The Company of Biologists Ltd 1993